Raloxifene for Osteoporosis | MyOsteoTeam

Connect with others who understand.

sign up log in
About MyOsteoTeam
Powered By

Raloxifene is a prescription medication approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis in postmenopausal women. Raloxifene is also sold under the brand name Evista.

Raloxifene is a selective estrogen receptor modulator (SERM). Raloxifene is believed to work by mimicking the effects of estrogen, which helps protect bone density.

How do I take it?
Raloxifene is taken once daily. Ask your doctor whether you need to take daily calcium and vitamin D supplements while on Raloxifene.

Raloxifene is available as a tablet.

Side effects
The FDA-approved label for Raloxifene lists common side effects including hot flashes and leg cramps.

Rare but serious side effects listed for Raloxifene include venous thromboembolism (potentially life-threatening blood clots in the lungs or leg veins), superficial thrombophlebitis (inflammation caused by blood clots just beneath the skin), increased risk for death due to stroke, and elevated triglycerides (blood fats).

For more details about this treatment, visit:

Evista - RxList

Raloxifene (Evista) - National Osteoporosis Foundation

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of Use and Privacy Policy.
Already a Member? Log in